Concert Pharmaceutic (CNCE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2018 | 09-2018 | 06-2018 | 03-2018 | 12-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -56,024 | -35,175 | -17,788 | -4,463 | 95,639 |
| Depreciation Amortization | 75 | 52 | -7 | 4 | 940 |
| Accounts receivable | 119 | 155 | 130 | 6 | -107 |
| Accounts payable and accrued liabilities | 435 | 457 | 183 | 236 | 113 |
| Other Working Capital | 3,970 | 2,961 | 312 | -2,169 | -2,473 |
| Other Operating Activity | 3,396 | -865 | -4,035 | -6,099 | 9,972 |
| Operating Cash Flow | $-48,029 | $-32,415 | $-21,205 | $-12,485 | $104,084 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 40,772 | 47,024 | 53,715 | 20,173 | -120,360 |
| PPE Investments | -2,869 | -2,405 | -1,521 | -325 | -947 |
| Investing Cash Flow | $37,903 | $44,619 | $52,194 | $19,848 | $-121,307 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | N/A | 29,659 |
| Debt Repayment | N/A | N/A | N/A | N/A | -30,745 |
| Common Stock Issued | N/A | 934 | 911 | 669 | N/A |
| Common Stock Repurchased | -1,206 | -1,206 | -1,206 | N/A | N/A |
| Other Financing Activity | 1,037 | 0 | 0 | 0 | 6,576 |
| Financing Cash Flow | $-169 | $-272 | $-295 | $669 | $5,490 |
| Beginning Cash Position | 29,222 | 29,222 | 29,222 | 29,222 | 40,955 |
| End Cash Position | 18,927 | 41,154 | 59,916 | 37,254 | 29,222 |
| Net Cash Flow | $-10,295 | $11,932 | $30,694 | $8,032 | $-11,733 |
| Free Cash Flow | |||||
| Operating Cash Flow | -48,029 | -32,415 | -21,205 | -12,485 | 104,084 |
| Capital Expenditure | -2,869 | -2,405 | -1,521 | -325 | -947 |
| Free Cash Flow | -50,898 | -34,820 | -22,726 | -12,810 | 103,137 |